Heat Biologics to Present at the 20th Annual B. Riley FBR Institutional Investor Conference May 20, 2019
Heat Biologics to Present at the Chinese Society for Clinical Oncology Conference on Immunotherapy Mar 21, 2019
Heat Biologics Lead Director to Chair Oncology Roundtable Discussion at WuXi Healthcare Forum in Shanghai Mar 5, 2019
Heat Biologics Presents Interim Phase 2 Lung Cancer Data on HS-110 + Nivolumab at ASCO-SITC Clinical Immuno-Oncology Symposium Feb 28, 2019
UPDATE: Heat Biologics Doses First Patient in New Cohort of its Expanded Phase 2 Trial of HS-110 in Combination with Merck's KEYTRUDA(R) in Non-Small Cell Lung Cancer Trial Jan 14, 2019
